ENDPOINTS

Verve is latest gene editing company to suffer setback as Vertex walks away from pact

Verve Therapeutics has not escaped the doom that seems to be engulfing the gene editing sector of late. The company said Thursday that Vertex Pharmaceuticals ...

Feb 27, 2025 - 17:25
 0
Verve is latest gene editing company to suffer setback as Vertex walks away from pact
Verve Therapeutics has not escaped the doom that seems to be engulfing the gene editing sector of late. The company said Thursday that Vertex Pharmaceuticals ...
Read More

Tags:

Previous Article

Mystery of how man's brain turned to glass after Vesuvius eruption possibly solved

Next Article

Mathematical model improves prediction of human mobility between cities

Related Posts

Supernus’ stock sinks after placebo effect derails mid-stage depression study

Supernus’ stock sinks after placebo effect derails mid-...

Feb 19, 2025  0

New CMO Dietmar Berger highlights Gilead’s ‘unique situation’ and its HIV ambitions

New CMO Dietmar Berger highlights Gilead’s ‘unique situ...

Feb 12, 2025  0

Kallyope quietly reports Phase 2 obesity data, begins mid-stage migraine trial

Kallyope quietly reports Phase 2 obesity data, begins m...

Feb 27, 2025  0